595 results on '"de Vries, Erik F J"'
Search Results
2. Non-invasive kinetic modelling approaches for quantitative analysis of brain PET studies
3. PET imaging of animal models with depressive-like phenotypes
4. Immune Activation in Pregnant Rats Affects Brain Glucose Consumption, Anxiety-like Behaviour and Recognition Memory in their Male Offspring
5. PET and SPECT Imaging of Neurotoxicity
6. PET Imaging in Multiple Sclerosis
7. Quantitative assessment of myelin density using [11C]MeDAS PET in patients with multiple sclerosis: a first-in-human study
8. The effect of lesion filling on brain network analysis in multiple sclerosis using structural magnetic resonance imaging
9. Potential PET tracers for imaging of tumor-associated macrophages
10. Validation and test–retest repeatability performance of parametric methods for [11C]UCB-J PET
11. Unsupervised Pattern Analysis to Differentiate Multiple Sclerosis Phenotypes Using Principal Component Analysis on Various MRI Sequences.
12. PET and SPECT Imaging of Steroid Hormone Receptors in the Brain
13. Interleukin-2 PET imaging in patients with metastatic melanoma before and during immune checkpoint inhibitor therapy
14. Pharmacokinetic and Pharmacodynamic Studies of Elacestrant, A Novel Oral Selective Estrogen Receptor Degrader, in Healthy Post-Menopausal Women
15. The Acute and Early Effects of Whole-Brain Irradiation on Glial Activation, Brain Metabolism, and Behavior: a Positron Emission Tomography Study
16. Pharmacokinetic Analysis of [18F]FES PET in the Human Brain and Pituitary Gland.
17. Perinatal exposure to the immune-suppressant di-n-octyltin dichloride affects brain development in rats.
18. Perinatal exposure to the immune-suppressant di-n-octyltin dichloride affects brain development in rats
19. PET Imaging in Multiple Sclerosis
20. PET and SPECT Imaging of Neurotoxicity
21. PET and SPECT Imaging of Steroid Hormone Receptors in the Brain
22. Preclinical Testing of Novel Radiotracers for Positron Emission Tomography (PET)
23. Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation
24. Detection of Dural Metastases Before the Onset of Clinical Symptoms by 16α-[18F]Fluoro-17β-Estradiol PET in a Patient With Estrogen Receptor–Positive Breast Cancer
25. Application of PET Tracers in Molecular Imaging for Breast Cancer
26. Visual and quantitative evaluation of [18F]FES and [18F]FDHT PET in patients with metastatic breast cancer: an interobserver variability study
27. Clinical Validity of 16α-[18F]Fluoro-17β-Estradiol Positron Emission Tomography/Computed Tomography to Assess Estrogen Receptor Status in Newly Diagnosed Metastatic Breast Cancer
28. Correlation between Histopathological Prognostic Tumor Characteristics and [ 18 F]FDG Uptake in Corresponding Metastases in Newly Diagnosed Metastatic Breast Cancer.
29. The association of childhood trauma with depressive and negative symptoms in recent onset psychosis: a sex-specific analysis.
30. Microglia Activation, Herpes Infection, and NMDA Receptor Inhibition: Common Pathways to Psychosis?
31. Antiviral treatment in schizophrenia: a randomized pilot PET study on the effects of valaciclovir on neuroinflammation
32. Correction to: Pharmacokinetic and Pharmacodynamic Studies of Elacestrant, A Novel Oral Selective Estrogen Receptor Degrader, in Healthy Post-Menopausal Women
33. Linking Molecular Neurobiology to Therapeutic Approaches for Alzheimer’s Disease with PET
34. PET and SPECT Imaging of Neurotoxicity
35. PET and SPECT Imaging of Steroid Hormone Receptors
36. Clinical-grade N-(4-[18F]fluorobenzoyl)-interleukin-2 for PET imaging of activated T-cells in humans
37. 99mTc-HYNIC-IL-2 scintigraphy to detect acute rejection in lung transplantation patients: a proof-of-concept study
38. Molecular imaging as biomarker for treatment response and outcome in breast cancer
39. sj-docx-1-tam-10.1177_17588359231170738 – Supplemental material for Molecular imaging as biomarker for treatment response and outcome in breast cancer
40. Effect of Preventive and Curative Fingolimod Treatment Regimens on Microglia Activation and Disease Progression in a Rat Model of Multiple Sclerosis
41. Radiation Dosimetry of a Novel Adenosine A2A Receptor Radioligand [11C]Preladenant Based on PET/CT Imaging and Ex Vivo Biodistribution in Rats
42. Quantitative myelin imaging with MRI and PET: an overview of techniques and their validation status
43. Hormonal Receptors PET-CT
44. PET/CT imaging of Mycobacterium tuberculosis infection
45. Impact of an Adenosine A2A Receptor Agonist and Antagonist on Binding of the Dopamine D2 Receptor Ligand [11C]raclopride in the Rodent Striatum
46. Binding of the Dual-Action Anti-Parkinsonian Drug AG-0029 to Dopamine D2 and Histamine H3 Receptors: A PET Study in Healthy Rats
47. PET imaging of oestrogen receptors in patients with breast cancer
48. Quantitative myelin imaging with MRI and PET: an overview of techniques and their validation status.
49. Positron emission tomography of tumour [18F]fluoroestradiol uptake in patients with acquired hormone-resistant metastatic breast cancer prior to oestradiol therapy
50. Evaluation of [11C]CB184 for imaging and quantification of TSPO overexpression in a rat model of herpes encephalitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.